VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 75 filers reported holding VYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 450,000 | $1,580,000 | 3.15% |
| DSC Advisors, L.P. | 1,100,000 | $3,861,000 | 2.79% |
| CM Management, LLC | 143,750 | $505,000 | 0.36% |
| Perceptive Advisors | 11,547,908 | $40,534,000 | 0.26% |
| DELTEC ASSET MANAGEMENT LLC | 386,491 | $1,357,000 | 0.19% |
| Tibra Equities Europe Ltd | 91,000 | $319,000 | 0.10% |
| 683 Capital Management, LLC | 733,683 | $2,575,000 | 0.09% |
| Banque Cantonale Vaudoise | 200,000 | $702,000 | 0.03% |
| Platform Technology Partners | 15,832 | $56,000 | 0.02% |
| Tekla Capital Management LLC | 135,395 | $475,000 | 0.02% |